Meyer H. Fedida

Synopsys in its pending $35 billion acquisition of Ansys, in its pending up to $2.1 billion sale of its Software Integrity business, and in the sale of its Optical Solutions Group.

Disney in the pending $8.5 billion merger of Star India with Viacom18 to form a new joint venture with Reliance.

T-Mobile in its pending $4.4 billion acquisition of UScellular’s wireless operations and select spectrum assets, and in its $1.35 billion acquisition of Ka’ena and its subsidiaries and brands, Mint Mobile, Ultra Mobile, and Plum.

Artémis in its acquisition of a majority stake in CAA from TPG.

Roquette in its pending acquisition of IFF’s Pharma Solutions business.

Keurig Dr Pepper in its pending acquisition of GHOST.

Cascade Investment in its $4.7 billion acquisition of Signature Aviation (as part of a consortium with Blackstone and Global Infrastructure Partners).

National Amusements (the Redstone family holding company) with respect to its investments in CBS and Viacom, including the $30.5 billion merger of CBS and Viacom.

General Motors in the sale of its Opel/Vauxhall subsidiaries and European financial operations to PSA Group.

Google in numerous transactions, including the sale of the assets of its Google Domains business to Squarespace and its acquisition of Raxium.

Solvay SA in the spin-off and listing of Syensqo (initial market capitalization of app. €9.5 billion).

Surescripts in its strategic partnership with TPG Capital.

Ecolab in the sale of its surgical solutions business to Medline.

Thales in its $3.6 billion acquisition of Imperva, its €4.8 billion tender offer for Gemalto, and its related divestment of its General Purpose Hardware Security Module business to Entrust.

GlaxoSmithKline in its announced up to $1.4 billion acquisition of Aiolos, and its $1.9 billion acquisition of Sierra Oncology.

Kindred Healthcare in its $4.1 billion sale to a consortium comprising TPG, Welsh Carson Anderson & Stowe, and Humana, and in its $1.8 billion acquisition of Gentiva Health Services.

LATAM Airlines in its $1.9 billion strategic partnership with Delta.

BNP Paribas in its novel transaction in relation to Deutsche Bank’s global prime brokerage and electronic equities businesses, and in its acquisition of Deutsche Bank’s Delta One hedge derivatives book.

Donatella Versace, GiVi Holding, and Jonathan Akeroyd in the $2.13 billion sale of Versace to Michael Kors.

Lafarge in its €40 billion merger of equals with Holcim to create LafargeHolcim.

Takeda Pharmaceutical Co. in its $5.2 billion acquisition of ARIAD Pharmaceuticals.

BHP Billiton in the demerger of South 32 (initial capitalization of $9.1 billion).

Alstom in its €6.2 billion acquisition of Bombardier Transportation.

Cohu in its acquisition of Xcerra.

Safran in the sale of its identity and security activities (Safran I&S) for €2.425 billion.

Amundi in its acquisition of a stake in Victory Capital through the transfer of 100% of its indirect interests in Amundi US to Victory Capital and previously in its €3.5 billion acquisition of Pioneer Investments from UniCredit.

Merck & Co. in its joint venture with Sanofi Pasteur for the exploitation of hexavalent vaccine Vaxelis.

ABB in its cable tray joint venture with Niedax and its acquisition of Siemens’ low voltage NEMA motor business.

Evraz Group S.A. in its $4 billion acquisition of IPSCO Inc. and simultaneous divestiture of certain of the purchased assets.

MEDNAX in its sales of American Anesthesiology to North American Partners in Anesthesia and MedData to Frazier Healthcare Partners.

Saint-Gobain in its acquisition of The Bailey Group of Companies, its C$1.325 billion acquisition of Building Products of Canada, and its $928 million acquisition of Kaycan.

Sysco in its acquisition of Edward Don & Company, of Greco and Sons, and of The Coastal Companies.

Sofidel in its $1.06 billion acquisition of Clearwater Paper Corporation’s tissue business.

Johnson Controls in the sale of its Air Distribution Technologies business to Truelink Capital and in its acquisition of workplace management software leader FM:Systems.

TPG (and its portfolio companies) in connection with various transactions including:

• Astound Broadband in its sale to Stonepeak Infrastructure Partners for $8.1 billion.
• TPG in its $1.3 billion sale of United Family Healthcare.
• RCN Telecom Services in its $2.36 billion acquisition of Wave Broadband;
• Cushman & Wakefield in its IPO and pre-IPO restructuring and previously DTZ in the $2 billion acquisition of Cushman & Wakefield, and TPG, PAG, and OTPP in the $1.2 billion acquisition of DTZ from UGL and of Cassidy Turley;
• Envision Pharmaceutical Holdings (a national, full-service pharmacy benefit management company) in its $2 billion sale to Rite Aid (and TPG in its prior acquisition of Envision Pharmaceutical Holdings); and
• TPG in its investments in Uber.

Warburg Pincus in several transactions.

Carlyle Global Partners in several transactions.

Sequoia and Paradigm in their $1.15 billion minority investment in Citadel Securities.

Groupe Marc de Lacharrière (the family holding company of Marc Ladreit de Lacharrière) in its investment resulting in a 5% stake in private equity firm Warburg Pincus.

TPG in a wide range of fund matters, including the formation and operation of its private equity, social impact, and other specialty funds, including TPG Partners V, VI, VII, VIII, and IX; TPG Healthcare Partners I and II; TPG Growth II, III, IV, and V; The Rise Fund I and II; and TPG Asia V, VI, VII, and VIII.

The Blackstone Group and Blackstone Alternative Asset Management in connection with various investment funds, including Blackstone Life Sciences Yield and Blackstone Life Sciences Fund V.

The Carlyle Group in connection with various investment funds.

Sequoia Capital in fund formation matters and in a number of investments in private funds.

Regular advisor to various large family offices and private foundations in their private equity investments.